Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
50
HEAL Quote, Financials, Valuation and Earnings
Last price:
$10.35
Seasonality move
:
-5.52%
Day range:
$10.43 - $10.55
52-week range:
$8.16 - $11.91
Dividend yield:
0.08%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
26.6K
Avg. volume:
38.6K
1-year change:
13.11%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
HEAL
Global X HealthTech ETF
|
-- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- |
|
CUT
Invesco MSCI Global Timber ETF
|
-- | -- | -- | -- | -- |
|
GNOM
Global X Genomics & Biotechnology ETF
|
-- | -- | -- | -- | -- |
|
SETM
Sprott Critical Materials ETF
|
-- | -- | -- | -- | -- |
|
WISE
Themes Generative Artificial Intelligence ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
HEAL
Global X HealthTech ETF
|
$10.44 | -- | -- | -- | $0.01 | 0.08% | -- |
|
AGNG
Global X Aging Population ETF
|
$32.20 | -- | -- | -- | $0.14 | 0.9% | -- |
|
CUT
Invesco MSCI Global Timber ETF
|
$30.66 | -- | -- | -- | $0.97 | 3.15% | -- |
|
GNOM
Global X Genomics & Biotechnology ETF
|
$8.72 | -- | -- | -- | $0.01 | 0.1% | -- |
|
SETM
Sprott Critical Materials ETF
|
$19.73 | -- | -- | -- | $0.31 | 1.57% | -- |
|
WISE
Themes Generative Artificial Intelligence ETF
|
$38.52 | -- | -- | -- | $0.00 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
HEAL
Global X HealthTech ETF
|
-- | 2.066 | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | 0.588 | -- | -- |
|
CUT
Invesco MSCI Global Timber ETF
|
-- | 0.845 | -- | -- |
|
GNOM
Global X Genomics & Biotechnology ETF
|
-- | 1.725 | -- | -- |
|
SETM
Sprott Critical Materials ETF
|
-- | 1.366 | -- | -- |
|
WISE
Themes Generative Artificial Intelligence ETF
|
-- | 1.318 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
HEAL
Global X HealthTech ETF
|
-- | -- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- | -- |
|
CUT
Invesco MSCI Global Timber ETF
|
-- | -- | -- | -- | -- | -- |
|
GNOM
Global X Genomics & Biotechnology ETF
|
-- | -- | -- | -- | -- | -- |
|
SETM
Sprott Critical Materials ETF
|
-- | -- | -- | -- | -- | -- |
|
WISE
Themes Generative Artificial Intelligence ETF
|
-- | -- | -- | -- | -- | -- |
Global X HealthTech ETF vs. Competitors
-
Which has Higher Returns HEAL or AGNG?
Global X Aging Population ETF has a net margin of -- compared to Global X HealthTech ETF's net margin of --. Global X HealthTech ETF's return on equity of -- beat Global X Aging Population ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital HEALGlobal X HealthTech ETF-- -- -- AGNGGlobal X Aging Population ETF-- -- -- -
What do Analysts Say About HEAL or AGNG?
Global X HealthTech ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X Aging Population ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Global X HealthTech ETF has higher upside potential than Global X Aging Population ETF, analysts believe Global X HealthTech ETF is more attractive than Global X Aging Population ETF.
Company Buy Ratings Hold Ratings Sell Ratings HEALGlobal X HealthTech ETF0 0 0 AGNGGlobal X Aging Population ETF0 0 0 -
Is HEAL or AGNG More Risky?
Global X HealthTech ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Global X Aging Population ETF has a beta of 0.736, suggesting its less volatile than the S&P 500 by 26.45%.
-
Which is a Better Dividend Stock HEAL or AGNG?
Global X HealthTech ETF has a quarterly dividend of $0.01 per share corresponding to a yield of 0.08%. Global X Aging Population ETF offers a yield of 0.9% to investors and pays a quarterly dividend of $0.14 per share. Global X HealthTech ETF pays -- of its earnings as a dividend. Global X Aging Population ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HEAL or AGNG?
Global X HealthTech ETF quarterly revenues are --, which are smaller than Global X Aging Population ETF quarterly revenues of --. Global X HealthTech ETF's net income of -- is lower than Global X Aging Population ETF's net income of --. Notably, Global X HealthTech ETF's price-to-earnings ratio is -- while Global X Aging Population ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Global X HealthTech ETF is -- versus -- for Global X Aging Population ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HEALGlobal X HealthTech ETF-- -- -- -- AGNGGlobal X Aging Population ETF-- -- -- --
-
Which has Higher Returns HEAL or CUT?
Invesco MSCI Global Timber ETF has a net margin of -- compared to Global X HealthTech ETF's net margin of --. Global X HealthTech ETF's return on equity of -- beat Invesco MSCI Global Timber ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital HEALGlobal X HealthTech ETF-- -- -- CUTInvesco MSCI Global Timber ETF-- -- -- -
What do Analysts Say About HEAL or CUT?
Global X HealthTech ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco MSCI Global Timber ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Global X HealthTech ETF has higher upside potential than Invesco MSCI Global Timber ETF, analysts believe Global X HealthTech ETF is more attractive than Invesco MSCI Global Timber ETF.
Company Buy Ratings Hold Ratings Sell Ratings HEALGlobal X HealthTech ETF0 0 0 CUTInvesco MSCI Global Timber ETF0 0 0 -
Is HEAL or CUT More Risky?
Global X HealthTech ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Invesco MSCI Global Timber ETF has a beta of 0.964, suggesting its less volatile than the S&P 500 by 3.551%.
-
Which is a Better Dividend Stock HEAL or CUT?
Global X HealthTech ETF has a quarterly dividend of $0.01 per share corresponding to a yield of 0.08%. Invesco MSCI Global Timber ETF offers a yield of 3.15% to investors and pays a quarterly dividend of $0.97 per share. Global X HealthTech ETF pays -- of its earnings as a dividend. Invesco MSCI Global Timber ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HEAL or CUT?
Global X HealthTech ETF quarterly revenues are --, which are smaller than Invesco MSCI Global Timber ETF quarterly revenues of --. Global X HealthTech ETF's net income of -- is lower than Invesco MSCI Global Timber ETF's net income of --. Notably, Global X HealthTech ETF's price-to-earnings ratio is -- while Invesco MSCI Global Timber ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Global X HealthTech ETF is -- versus -- for Invesco MSCI Global Timber ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HEALGlobal X HealthTech ETF-- -- -- -- CUTInvesco MSCI Global Timber ETF-- -- -- --
-
Which has Higher Returns HEAL or GNOM?
Global X Genomics & Biotechnology ETF has a net margin of -- compared to Global X HealthTech ETF's net margin of --. Global X HealthTech ETF's return on equity of -- beat Global X Genomics & Biotechnology ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital HEALGlobal X HealthTech ETF-- -- -- GNOMGlobal X Genomics & Biotechnology ETF-- -- -- -
What do Analysts Say About HEAL or GNOM?
Global X HealthTech ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X Genomics & Biotechnology ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Global X HealthTech ETF has higher upside potential than Global X Genomics & Biotechnology ETF, analysts believe Global X HealthTech ETF is more attractive than Global X Genomics & Biotechnology ETF.
Company Buy Ratings Hold Ratings Sell Ratings HEALGlobal X HealthTech ETF0 0 0 GNOMGlobal X Genomics & Biotechnology ETF0 0 0 -
Is HEAL or GNOM More Risky?
Global X HealthTech ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Global X Genomics & Biotechnology ETF has a beta of 1.197, suggesting its more volatile than the S&P 500 by 19.747%.
-
Which is a Better Dividend Stock HEAL or GNOM?
Global X HealthTech ETF has a quarterly dividend of $0.01 per share corresponding to a yield of 0.08%. Global X Genomics & Biotechnology ETF offers a yield of 0.1% to investors and pays a quarterly dividend of $0.01 per share. Global X HealthTech ETF pays -- of its earnings as a dividend. Global X Genomics & Biotechnology ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HEAL or GNOM?
Global X HealthTech ETF quarterly revenues are --, which are smaller than Global X Genomics & Biotechnology ETF quarterly revenues of --. Global X HealthTech ETF's net income of -- is lower than Global X Genomics & Biotechnology ETF's net income of --. Notably, Global X HealthTech ETF's price-to-earnings ratio is -- while Global X Genomics & Biotechnology ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Global X HealthTech ETF is -- versus -- for Global X Genomics & Biotechnology ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HEALGlobal X HealthTech ETF-- -- -- -- GNOMGlobal X Genomics & Biotechnology ETF-- -- -- --
-
Which has Higher Returns HEAL or SETM?
Sprott Critical Materials ETF has a net margin of -- compared to Global X HealthTech ETF's net margin of --. Global X HealthTech ETF's return on equity of -- beat Sprott Critical Materials ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital HEALGlobal X HealthTech ETF-- -- -- SETMSprott Critical Materials ETF-- -- -- -
What do Analysts Say About HEAL or SETM?
Global X HealthTech ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Sprott Critical Materials ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Global X HealthTech ETF has higher upside potential than Sprott Critical Materials ETF, analysts believe Global X HealthTech ETF is more attractive than Sprott Critical Materials ETF.
Company Buy Ratings Hold Ratings Sell Ratings HEALGlobal X HealthTech ETF0 0 0 SETMSprott Critical Materials ETF0 0 0 -
Is HEAL or SETM More Risky?
Global X HealthTech ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Sprott Critical Materials ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock HEAL or SETM?
Global X HealthTech ETF has a quarterly dividend of $0.01 per share corresponding to a yield of 0.08%. Sprott Critical Materials ETF offers a yield of 1.57% to investors and pays a quarterly dividend of $0.31 per share. Global X HealthTech ETF pays -- of its earnings as a dividend. Sprott Critical Materials ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HEAL or SETM?
Global X HealthTech ETF quarterly revenues are --, which are smaller than Sprott Critical Materials ETF quarterly revenues of --. Global X HealthTech ETF's net income of -- is lower than Sprott Critical Materials ETF's net income of --. Notably, Global X HealthTech ETF's price-to-earnings ratio is -- while Sprott Critical Materials ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Global X HealthTech ETF is -- versus -- for Sprott Critical Materials ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HEALGlobal X HealthTech ETF-- -- -- -- SETMSprott Critical Materials ETF-- -- -- --
-
Which has Higher Returns HEAL or WISE?
Themes Generative Artificial Intelligence ETF has a net margin of -- compared to Global X HealthTech ETF's net margin of --. Global X HealthTech ETF's return on equity of -- beat Themes Generative Artificial Intelligence ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital HEALGlobal X HealthTech ETF-- -- -- WISEThemes Generative Artificial Intelligence ETF-- -- -- -
What do Analysts Say About HEAL or WISE?
Global X HealthTech ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Themes Generative Artificial Intelligence ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Global X HealthTech ETF has higher upside potential than Themes Generative Artificial Intelligence ETF, analysts believe Global X HealthTech ETF is more attractive than Themes Generative Artificial Intelligence ETF.
Company Buy Ratings Hold Ratings Sell Ratings HEALGlobal X HealthTech ETF0 0 0 WISEThemes Generative Artificial Intelligence ETF0 0 0 -
Is HEAL or WISE More Risky?
Global X HealthTech ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Themes Generative Artificial Intelligence ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock HEAL or WISE?
Global X HealthTech ETF has a quarterly dividend of $0.01 per share corresponding to a yield of 0.08%. Themes Generative Artificial Intelligence ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Global X HealthTech ETF pays -- of its earnings as a dividend. Themes Generative Artificial Intelligence ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HEAL or WISE?
Global X HealthTech ETF quarterly revenues are --, which are smaller than Themes Generative Artificial Intelligence ETF quarterly revenues of --. Global X HealthTech ETF's net income of -- is lower than Themes Generative Artificial Intelligence ETF's net income of --. Notably, Global X HealthTech ETF's price-to-earnings ratio is -- while Themes Generative Artificial Intelligence ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Global X HealthTech ETF is -- versus -- for Themes Generative Artificial Intelligence ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HEALGlobal X HealthTech ETF-- -- -- -- WISEThemes Generative Artificial Intelligence ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
80
SOC alert for Jul 18
Sable Offshore [SOC] is up 11.82% over the past day.
Buy
71
PGY alert for Jul 18
Pagaya Technologies [PGY] is up 6.14% over the past day.
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 0.29% over the past day.
